[Treatment of psychiatric and behavioural symptoms in Alzheimer's disease].
D000544:Alzheimer Disease / Q000523:psychology* / Q000628:therapy*; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001526:Behavioral Symptoms; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000209:etiology* / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D018691:Excitatory Amino Acid Antagonists; D017367:Selective Serotonin Reuptake Inhibitors
Traitement médical des manifestations psychiatriques et comportementales de la maladie d'Alzheimer.